Images in Emergency Medicine: Dermatomyositis by Kidane, Senai & Snoey, Eric R.
Volume IX, n o . 2  :  May 2008                                                 127                               The Western Journal of Emergency Medicine 
LAC+USC Medical Center, Department of Emergency Medicine 
Senai Kidane, MD
Eric R. Snoey, MD
im a g e s  in em e r g e n c y  me d i c i n e
Images in Emergency Medicine: Dermatomyositis
Alameda County Medical Center, Department of Emergency Medicine
Supervising Section Editor: Rick A. McPheeters, DO
Submission history: Submitted December 6, 2007; Revision Received February 4, 2008; Accepted February 4, 2008.
Reprints available through open access at www.westjem.org
[WestJEM. 2008;9:127-128.]
A 41-year-old Guatemalan woman with a history of 
remote uterine cancer presented to an urban community 
Emergency Department complaining of a pruritic, initially 
painful rash on her chest, eyelids, thighs, and elbows for 
three weeks. She also stated she had weakness in her thighs 
and shoulders with difficulty standing. She denied any new 
exposures (ex. foods, clothes, soaps, fragrances, medicines, 
or illicit drugs), recent travel, bites, or recent trauma. She 
denied fever, night sweats, weight loss, recent illnesses, or 
sick contacts. Her vital signs were normal and stable. On 
exam she was found to have circumferential, violaceous 
patches on her eyelids and proximal chest, and erythematous 
patches on the extensor surfaces of her elbows and in a malar 
distribution on her face. She was noted to have proximal 
thigh weakness and was unable to get up from a chair 
without assistance. The remainder of her exam, including 
sensation, cranial nerves, and distal motor function, was 
otherwise unremarkable. Laboratory studies were remarkable 
for an AST of 336, ALT of 158, LDH of 1948, CK of 9031, 
and ANA +. Her CBC and remaining metabolic panel were 
within normal limits. She was presumptively diagnosed 
with dermatomyositis and referred to general medicine and 
rheumatology clinics where she was started on a course of 
Prednisone with marked resolution of her symptoms. She 
recovered without sequelae.
Dermatomyositis (DM) is part of spectrum of idiopathic 
inflammatory myopathies. It has a prevalence rate estimated 
at approximately one per 100,000 in the general population 
with a 2:1 female predominance, and peak incidence 
between the ages of 40 and 50. Diagnosis is largely clinical 
and includes symmetric, proximal muscle weakness, 
characteristic rash, and elevated muscle enzymes. Common 
skin findings include Gottron’s sign (symmetric, roughened, 
erythematous skin changes over the extensor surfaces of the 
metacarpophalangeal and interphalangeal joints, elbows, or 
knees), heliotrope rash (a violaceous eruption on the upper 
eyelids sometimes accompanied by edema), and shawl sign 
(a diffuse flat erythema in a shawl-like distribution over the 
chest and shoulder, or a V-shaped pattern over the anterior 
neck and chest).
Both measurement of serum muscle enzyme levels (CK, 
LDH, aldolase, AST, ALT) and testing for the presence of 
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myositis-specific autoantibodies play important diagnostic 
and prognostic roles in the assessment of patients with 
suspected DM. Other diagnostic and prognostic modalities 
include electromyography, MRI, and tissue biopsy. Prognosis 
is related to the severity of symptoms. Significant associated 
complications are not uncommon and can include interstitial 
lung disease and malignancy, and to a lesser extent esophageal 
disease and myocarditis. Therapy should be guided primarily 
by the degree of motor involvement and consists primarily of 
glucocorticoids and supportive therapy.
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